Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis
Authors:
- 16 April 2009
- journal article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 44 (6) , 630-634
Abstract
Among patients with asymptomatic primary biliary cirrhosis (a-PBC), a substantial portion ultimately develop symptoms suggestive of liver injury. Prognostic variables to distinguish patients likely to become symptomatic from patients who will remain asymptomatic need to be identified. We examined the impact of biochemical response to ursodeoxycholic acid in the development of symptoms in patients with a-PBC. Subjects comprised 83 patients with a-PBC treated using ursodeoxycholic acid (UDCA). All patients were followed regularly every 1–3 months. Response to treatment with UDCA was defined as a decrease in γ-glutamyl transpeptidase (GGT) ≥70% of pretreatment or normal levels from 6 months after start of treatment. During the follow-up period (62.1 ± 52.7 months), 12 patients (14.5%) developed liver-related symptoms. Incidence of the development of liver-related symptoms was significantly higher in UDCA non-responders than in responders (p < 0.001). Multivariate analysis showed that response to UDCA (improvement of GGT) represents an independent factor for predicting symptom development in patients with a-PBC. Patients with a-PBC showing lack of biochemical response to UDCA by 6 months after treatment commencement should be considered for further treatments.Keywords
This publication has 23 references indexed in Scilit:
- Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosisHepatology, 2008
- The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter studyHepatology Research, 2008
- Excellent Long-Term Survival in Patients With Primary Biliary Cirrhosis and Biochemical Response to Ursodeoxycholic AcidGastroenterology, 2006
- The Effect of Ursodeoxycholic Acid Therapy on Liver Fibrosis Progression in Primary Biliary CirrhosisHepatology, 2000
- Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosisJournal of Hepatology, 1999
- Long–Term Ursodeoxycholic Acid Delays Histological Progression in Primary Biliary CirrhosisHepatology, 1999
- Primary Biliary CirrhosisNew England Journal of Medicine, 1996
- Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 yearsJournal of Hepatology, 1994
- A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary CirrhosisNew England Journal of Medicine, 1991
- Primary Biliary Cirrhosis: Clinical Features and Outcome, with Special Reference to Asymptomatic DiseaseScandinavian Journal of Gastroenterology, 1989